BR0015333A - Derivados de isoxazol como inibidores de fosfodiesterase vii - Google Patents

Derivados de isoxazol como inibidores de fosfodiesterase vii

Info

Publication number
BR0015333A
BR0015333A BR0015333-8A BR0015333A BR0015333A BR 0015333 A BR0015333 A BR 0015333A BR 0015333 A BR0015333 A BR 0015333A BR 0015333 A BR0015333 A BR 0015333A
Authority
BR
Brazil
Prior art keywords
vii
phosphodiesterase inhibitors
isoxazole derivatives
derivatives
inhibitors
Prior art date
Application number
BR0015333-8A
Other languages
English (en)
Inventor
Hans-Michael Eggenweiler
Rochus Jonas
Michael Wolf
Michael Gassen
Thomas Welge
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of BR0015333A publication Critical patent/BR0015333A/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/04Antipruritics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • AIDS & HIV (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Obesity (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)

Abstract

Patente de Invenção: "DERIVADOS DE ISOXAZOL COMO INIBIDORES DE FOSFODIESTERASE VII". A invenção refere-se a compostos de fórmula (I), em que R^ 1^, R^ 2^, R^ 3^, R^ 4^ e R^ 5^ têm os significados indicados na reivindicação 1 e aos seus sais e/ou solvatos fisiologicamente aceitáveis, que são usados como os inibidores de fosfodiesterase VII, e ao uso deles na produção de medicamentos.
BR0015333-8A 1999-11-04 2000-10-18 Derivados de isoxazol como inibidores de fosfodiesterase vii BR0015333A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19953024A DE19953024A1 (de) 1999-11-04 1999-11-04 Isoxazolderivate als Phosphodiesterase VII-Hemmer
PCT/EP2000/010239 WO2001032175A1 (de) 1999-11-04 2000-10-18 Isoxazolderivate als phosphodiesterase vii-hemmer

Publications (1)

Publication Number Publication Date
BR0015333A true BR0015333A (pt) 2002-07-09

Family

ID=7927860

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0015333-8A BR0015333A (pt) 1999-11-04 2000-10-18 Derivados de isoxazol como inibidores de fosfodiesterase vii

Country Status (20)

Country Link
US (1) US6531498B1 (pt)
EP (1) EP1225896B1 (pt)
JP (1) JP2003513042A (pt)
KR (1) KR20020047329A (pt)
CN (1) CN1384744A (pt)
AR (1) AR026350A1 (pt)
AT (1) ATE300945T1 (pt)
AU (1) AU781607B2 (pt)
BR (1) BR0015333A (pt)
CA (1) CA2389647C (pt)
CZ (1) CZ20021441A3 (pt)
DE (2) DE19953024A1 (pt)
ES (1) ES2243313T3 (pt)
HU (1) HUP0203187A3 (pt)
MX (1) MXPA02004441A (pt)
NO (1) NO20022123L (pt)
PL (1) PL355021A1 (pt)
RU (1) RU2002113746A (pt)
SK (1) SK5942002A3 (pt)
WO (1) WO2001032175A1 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2255294T3 (es) * 1998-08-07 2006-06-16 Chiron Corporation Derivados de isoxazol sustituidos como moduladores del receptor de estrogenos.
ES2217956B1 (es) * 2003-01-23 2006-04-01 Almirall Prodesfarma, S.A. Nuevos derivados de 4-aminotieno(2,3-d)pirimidin-6-carbonitrilo.
US20050107350A1 (en) * 2003-08-22 2005-05-19 Pharmacia Corporation Method for the treatment or prevention of bone disorders with a cyclooxygenase-2 inhibitor alone and in combination with a bone disorder treatment agent and compositions therewith
KR100666052B1 (ko) * 2004-02-12 2007-01-09 조극래 원적외선이용한 건조장치
ES2814200T3 (es) 2005-07-29 2021-03-26 Basf Se Estabilización de productos para el cuidado del cuerpo y del hogar contra la degradación por radiación UV utilizando derivados de merocianina
US8637528B2 (en) * 2007-03-27 2014-01-28 Omeros Corporation Use of PDE7 inhibitors for the treatment of movement disorders
RU2449790C2 (ru) * 2007-03-27 2012-05-10 Омерос Корпорейшен Использование ингибиторов pde7 для лечения нарушений движения
WO2012064667A2 (en) 2010-11-08 2012-05-18 Omeros Corporation Treatment of addiction and impulse-control disorders using pde7 inhibitors
US9220715B2 (en) 2010-11-08 2015-12-29 Omeros Corporation Treatment of addiction and impulse-control disorders using PDE7 inhibitors
CN104725329B (zh) * 2015-01-13 2017-01-18 陕西科技大学 一种具有抗肿瘤活性的异恶唑羧酸类化合物及其合成方法
AU2018300091B2 (en) 2017-07-12 2023-06-22 Dart Neuroscience, Llc Substituted benzoxazole and benzofuran compounds as PDE7 inhibitors
WO2024038090A1 (en) 2022-08-18 2024-02-22 Mitodicure Gmbh Use of substituted benzoxazole and benzofuran compounds for the treatment and prevention of diseases associated with chronic fatigue, exhaustion and/or exertional intolerance

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU658629B2 (en) * 1991-05-01 1995-04-27 Taiho Pharmaceutical Co., Ltd. Novel isoxazole derivative and salt thereof
KR0182324B1 (ko) * 1993-11-26 1999-05-01 알렌 제이. 스피겔 항염증제로서의 이속사졸린 화합물
CA2177375A1 (en) * 1993-11-26 1995-06-01 Edward F. Kleinman 3-aryl-2-isoxazolines as antiinflammatory agents

Also Published As

Publication number Publication date
PL355021A1 (en) 2004-03-22
KR20020047329A (ko) 2002-06-21
MXPA02004441A (es) 2004-09-10
CA2389647C (en) 2010-08-10
AU781607B2 (en) 2005-06-02
NO20022123D0 (no) 2002-05-03
CA2389647A1 (en) 2001-05-10
ES2243313T3 (es) 2005-12-01
HUP0203187A3 (en) 2004-12-28
CN1384744A (zh) 2002-12-11
DE19953024A1 (de) 2001-05-10
RU2002113746A (ru) 2004-01-10
HUP0203187A2 (hu) 2003-01-28
EP1225896B1 (de) 2005-08-03
WO2001032175A1 (de) 2001-05-10
CZ20021441A3 (cs) 2002-07-17
NO20022123L (no) 2002-05-03
EP1225896A1 (de) 2002-07-31
US6531498B1 (en) 2003-03-11
SK5942002A3 (en) 2002-09-10
AU1026201A (en) 2001-05-14
JP2003513042A (ja) 2003-04-08
AR026350A1 (es) 2003-02-05
ATE300945T1 (de) 2005-08-15
DE50010885D1 (de) 2005-09-08

Similar Documents

Publication Publication Date Title
BRPI0112986B8 (pt) compostos azabicíclicos, processo para a sua preparação, bem como composições farmacêuticas compreendendo os ditos compostos
BR0111263A (pt) Derivados de 2-aminocarbonil-9h-purina
BR0111667A (pt) Novos compostos
BR0307267A (pt) Compostos heterocìclicos, ativos como inibidores de beta-lacta-mases
PT1295890E (pt) Novos derivados de pirazina ou os seus sais, composicoes farmaceuticas que os contem, e compostos intermedios utilizados na sua producao
BR0215240A (pt) Derivados de calcona e seu uso no tratamento de doenças
BR9812010A (pt) Determinados ácidos 5-alquil-2-arilaminofenilacéticos e derivados
BR0211805A (pt) Herbicidas
BR9810021A (pt) Derivados 9-oxima-eritromicina
DE60121461D1 (de) Kondensierte pyridoindolderivate
BR0015333A (pt) Derivados de isoxazol como inibidores de fosfodiesterase vii
BR0114159A (pt) Herbicidas de fenilpropiniloxipiridina
BR0108605A (pt) Derivados de 8,8a-dihidro-indeno[1,2-d]tiazol, que na posição 8a são substituìdos; processos para a sua preparação e seu emprego como medicamentos, por exemplo, como anoréxicos
DE60112306D1 (de) Kondensierte pyrazindionderivate als pde5 inhibitore
BR0109542A (pt) Derivados de imidazopirina alquilados
BR9905089A (pt) Derivados macrolìdeos
BRPI0418255A (pt) derivados de piperazina e piperidina n-substituìdos
DE60112960D1 (de) Kondensierte pyridoindolderivate
BR0002505A (pt) Derivados de 4-arilpiperidina para o tratamento de prurido
BR9813719A (pt) Agentes terapêuticos
BR0111669A (pt) Novos compostos
BR0318659A (pt) derivados de prolina usados como ingredientes farmacêuticos ativos no tratamento de tumores
SE0102057D0 (sv) New Salts I
ATE293111T1 (de) Kondensierte pyrazindionderivate als pde inhibitoren
ATE330958T1 (de) Pyrazino 1'2':1,6öpyrido 3,4-böindolderivate

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]